Stockscreener 앱 받기
452.00
0.34%
-1.54
시간 외 거래:
452.00
Alnylam Pharmaceuticals Inc 주식(ALNY)의 최신 뉴스
How Investors May Respond To Alnylam Pharmaceuticals (ALNY) Positive Long-Term HELIOS-B Results for AMVUTTRA - simplywall.st
Is Alnylam Pharmaceuticals Inc. a defensive stockJuly 2025 Momentum & Reliable Breakout Stock Forecasts - خودرو بانک
Is Alnylam Pharmaceuticals Inc. exposed to political riskJuly 2025 Decliners & Community Consensus Trade Signals - خودرو بانک
What are Alnylam Pharmaceuticals Inc.’s earnings expectationsEarnings Beat & Safe Entry Point Alerts - خودرو بانک
Intraday pattern recognizer results for Alnylam Pharmaceuticals Inc.2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
Visual analytics tools that track Alnylam Pharmaceuticals Inc. performance2025 Year in Review & Momentum Based Trading Ideas - Newser
Published on: 2025-09-06 00:28:49 - خودرو بانک
Can Alnylam Pharmaceuticals Inc. be the next market leader2025 Investor Takeaways & Reliable Volume Spike Trade Alerts - خودرو بانک
What to expect from Alnylam Pharmaceuticals Inc. in the next 30 days2025 Year in Review & Fast Exit and Entry Strategy Plans - Newser
Published on: 2025-09-05 14:03:59 - Newser
How to use a screener to detect Alnylam Pharmaceuticals Inc. breakoutsPortfolio Performance Summary & Free Fast Gain Swing Trade Alerts - Newser
Using RSI to spot recovery in Alnylam Pharmaceuticals Inc.Rate Cut & Safe Entry Point Identification - Newser
How high can Alnylam Pharmaceuticals Inc. stock goTrend Reversal & Reliable Trade Execution Plans - Newser
Multi asset correlation models including Alnylam Pharmaceuticals Inc.GDP Growth & AI Forecast Swing Trade Picks - Newser
Alnylam Pharmaceuticals' (ALNY) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock? - Nasdaq
Best data tools to analyze Alnylam Pharmaceuticals Inc. stockWeekly Stock Report & Momentum Based Trading Ideas - Newser
RNA Therapeutics Market Size, Top Share | Industry Report, 2034 - Straits Research
Applying big data sentiment scoring on Alnylam Pharmaceuticals IncMarket Trend Report & High Return Trade Guides - Newser
Gene Therapy Market is expected to reach US$ 35.91 Billion by 2033 - openPR.com
Will Alnylam Pharmaceuticals Inc. outperform small cap indexes2025 Buyback Activity & Real-Time Buy Zone Alerts - خودرو بانک
Key resistance and support levels for Alnylam Pharmaceuticals Inc.2025 AllTime Highs & Weekly Top Gainers Trade List - Newser
Regeneron posts late-stage trial win for myasthenia gravis drug developed with Alnylam - MSN
What does recent volatility data suggest for Alnylam Pharmaceuticals Inc.2025 Trade Ideas & Reliable Intraday Trade Alerts - Newser
Strategies to average down on Alnylam Pharmaceuticals Inc.Market Movers & Safe Entry Point Alerts - Newser
Quantitative breakdown of Alnylam Pharmaceuticals Inc. recent move2025 Technical Overview & Safe Entry Trade Signal Reports - Newser
What moving averages say about Alnylam Pharmaceuticals Inc.2025 Macro Impact & Free Daily Entry Point Trade Alerts - Newser
Using Python tools to backtest Alnylam Pharmaceuticals Inc. strategiesJuly 2025 Summary & Daily Technical Forecast Reports - Newser
Market reaction to Alnylam Pharmaceuticals Inc.’s recent news2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - Newser
Alnylam at Citi’s Biopharma Conference: Launch Success and Future Plans - Investing.com
Sentiment analysis tools applied to Alnylam Pharmaceuticals Inc.July 2025 Opening Moves & Free Weekly Watchlist of Top Performers - Newser
The Strategic Value of Novartis' $5.2 Billion Argo Biopharma Licensing Deal in the RNAi Cardiovascular Therapeutics Space - AInvest
Technical analysis overview for Alnylam Pharmaceuticals Inc. stockJuly 2025 Outlook & Stepwise Trade Signal Implementation - Newser
How institutional ownership impacts Alnylam Pharmaceuticals Inc. stockJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Technical signs of recovery in Alnylam Pharmaceuticals Inc.July 2025 Volume & Fast Gaining Stock Reports - Newser
Will breakout in Alnylam Pharmaceuticals Inc. lead to full recovery2025 Earnings Surprises & Safe Entry Point Alerts - Newser
What MACD and RSI say about Alnylam Pharmaceuticals Inc.Earnings Summary Report & Weekly High Potential Alerts - Newser
Using fundamentals and technicals on Alnylam Pharmaceuticals Inc.2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Published on: 2025-09-03 01:05:50 - Newser
Alnylam Pharmaceuticals: Amvuttra's Launch And Ongoing Clinical Progress Are Positives - Seeking Alpha
Alnylam Pharmaceuticals Inc.’s volatility index tracking explained2025 Volume Leaders & AI Powered Trade Plan Recommendations - Newser
Chart overlay techniques for tracking Alnylam Pharmaceuticals Inc.Forecast Cut & High Accuracy Trade Alerts - Newser
What’s the analyst consensus on Alnylam Pharmaceuticals Inc.Stock Surge & Weekly Return Optimization Plans - خودرو بانک
Alnylam Shares Edge Up 0.11% on $480M Volume (Rank 222nd) as RNAi Pipeline Drives 70%+ Total Return - AInvest
How sentiment analysis helps forecast Alnylam Pharmaceuticals Inc.Quarterly Performance Summary & Weekly Watchlist for Consistent Profits - Newser
Is Alnylam Pharmaceuticals Inc. forming a breakout pattern2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - خودرو بانک
1.09%
자본화:
|
볼륨(24시간):